Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

NCT07711327 is registered in ClinicalTrials.gov with Tina Baykaner as lead sponsor.

NCT NCT07711327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07711327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
Lead sponsor
Tina Baykaner
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2031
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), chronic lymphocytic leukemia, mantle cell lymphoma, marginal zone lymphoma, waldenstrom macroglobulinemia